135 related articles for article (PubMed ID: 2449649)
1. [Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
Allannic H; Genetet N; Edan G; Merdrignac G; Simon M; Genetet B
Pathol Biol (Paris); 1987 Dec; 35(10):1333-8. PubMed ID: 2449649
[TBL] [Abstract][Full Text] [Related]
2. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
4. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
5. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
6. Characterization of lymphoid cells in the thyroid of patients with Graves' disease.
Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B
Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996
[TBL] [Abstract][Full Text] [Related]
7. Activated T cells in Graves' disease before treatment.
Kennedy R; Di Mario U; Pozzilli P; Guy K; Leonardi M; Sensi M; Andreani D
Clin Exp Immunol; 1985 Feb; 59(2):377-82. PubMed ID: 3156702
[TBL] [Abstract][Full Text] [Related]
8. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.
Charreire J; Karsenty G; Bouchard P; Schaison G
Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216
[TBL] [Abstract][Full Text] [Related]
9. [Intrathyroidal lymphocytes in autoimmune thyroid diseases].
Aguayo J; Wohlik N; Baeza A; Carrasco AM; Pineda G
Rev Med Chil; 1994 Jan; 122(1):19-26. PubMed ID: 8066339
[TBL] [Abstract][Full Text] [Related]
10. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status.
Bonnyns M; Bentin J; Devetter G; Duchateau J
Clin Exp Immunol; 1983 Jun; 52(3):629-34. PubMed ID: 6223729
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
Liao ZQ
Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):162-4. PubMed ID: 2144488
[TBL] [Abstract][Full Text] [Related]
13. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.
Martin A; Goldsmith NK; Friedman EW; Schwartz AE; Davies TF; Roman SH
Autoimmunity; 1990; 6(4):269-81. PubMed ID: 1716476
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of Graves' disease.
Gossage AA; Munro DS
Clin Endocrinol Metab; 1985 May; 14(2):299-330. PubMed ID: 2866051
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thyroid disease--a perspective.
Volpé R
Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
17. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
Peakman M; Hussain M; Cundy T; Vergani D
J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
[TBL] [Abstract][Full Text] [Related]
19. Abnormal distribution of gammadelta T lymphocytes in Graves' disease and insulin-dependent diabetes type 1.
Kretowski A; Myśliwiec J; Kinalska I
Arch Immunol Ther Exp (Warsz); 2000; 48(1):39-42. PubMed ID: 10722230
[TBL] [Abstract][Full Text] [Related]
20. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
